Author

S. Schelenz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:fungi (other)· 3 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Assay:DNA methylation· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Abdolrasouli· 1 shared A. F. Talento· 1 shared A. Griffin· 1 shared A. Lorenz· 1 shared A. M. Edwards· 1 shared A. Nuh· 1 shared A. Sabnis· 1 shared B. Simmons· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Abdolrasouli

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genomic epidemiology of European Aspergillus fumigatus causing COVID-19-associated pulmonary aspergillosis in Europe

B. Simmons, J. Rhodes, T. Rogers, A. F. Talento, A. Griffin, M. Mansfield, A. Abdolrasouli, P. E. Verweij, T. Bosch, S. Schelenz, S. Hemmings, D. Sheehan, M. C. Fisher

This study analyzes the genomic epidemiology of Aspergillus fumigatus causing CAPA in Europe, finding no unique genetic background but a notable prevalence of azole-resistance alleles.

bioRxiv · Jul 21, 2023 · PreprintMicrobiology

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin Against Cystic Fibrosis Pseudomonas aeruginosa

R. A. Murphy, M. Coates, S. Thrane, A. Sabnis, J. Harrison, S. Schelenz, A. M. Edwards, T. Vorup-Jensen, J. C. Davies

This study shows that glatiramer acetate enhances tobramycin's effectiveness against Pseudomonas aeruginosa in cystic fibrosis patients by reducing MICs and disrupting bacterial membranes.

bioRxiv · Feb 3, 2022Microbiology

Comparative Evaluation of Micronaut-AM and CLSI broth micro-dilution method for antifungal susceptibility testing of Aspergillus species against four commonly used antifungals

A. Nuh, N. Ramadan, S. Schelenz, D. Armstrong-James

This study compares the Micronaut-AM colorimetric method to the CLSI broth micro-dilution method for antifungal susceptibility testing of Aspergillus species, finding high agreement and faster results.

bioRxiv · Oct 30, 2019Microbiology

Rapid and extensive karyotype diversification in haploid clinical Candida auris isolates

G. Bravo Ruiz, Z. K. Ross, S. Schelenz, N. A. R. Gow, A. Lorenz

This study examines karyotype variability in haploid Candida auris isolates, showing rapid chromosomal changes under stress and no clear link to drug resistance or clade.

bioRxiv · Jan 9, 2019Microbiology